Prediction of Immune-Related Adverse Events Induced by Immune Checkpoint Inhibitors With a Panel of Autoantibodies: Protocol of a Multicenter, Prospective, Observational Cohort Study

Introduction: Immune checkpoint inhibitor (ICI) therapy is markedly improving the prognosis of patients with several types of cancer. On the other hand, the growth in the use of these drugs in oncology is associated with an increase in multiple immune-related adverse events (irAEs), whose optimal pr...

Descrizione completa

Dettagli Bibliografici

Autori principali:	Iñigo Les, Inés Pérez-Francisco, María Cabero, Cristina Sánchez, María Hidalgo, Lucía Teijeira, Virginia Arrazubi, Severina Domínguez, Pilar Anaut, Saioa Eguiluz, Iñaki Elejalde, Alberto Herrera, Mireia Martínez
Natura:	Artigo
Lingua:	Inglês
Pubblicazione:	Frontiers Media S.A. 2022-06-01
Serie:	Frontiers in Pharmacology
Soggetti:	immune checkpoint inhibitors immune-related adverse events cancer autoantibodies prospective cohort study multicenter
Accesso online:	https://www.frontiersin.org/articles/10.3389/fphar.2022.894550/full
Tags:	Aggiungi Tag Nessun Tag, puoi essere il primo ad aggiungerne!!